☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
POETYK PSO-1
BMS' Deucravacitinib (BMS-986165) Demonstrate Superiority Over Amgen' Otezla (apremilast) in P-III POETYK PSO-1 Study for Plaque P...
November 4, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.